BiotechTube
Home/Shattuck Labs/Taylor H. Schreiber
TH

Taylor H. Schreiber

Chief Executive Officer and Co-founder

Shattuck Labs

Therapeutic Areas

Inflammatory Bowel DiseaseAutoimmune Diseases

Shattuck Labs Pipeline

DrugIndicationPhase
SL-325Inflammatory Bowel Disease (IBD)Phase 2
SL-425Inflammatory Bowel Disease (IBD)Phase 1
BispecificsAutoimmune DiseasesIND-Enabling

Leadership Team at Shattuck Labs

LP
Lini Pandite
Chief Medical Officer
CD
Casi DeYoung
Chief Business Officer
AR
Andrew R. Neill
Chief Financial Officer
View full Shattuck Labs profile